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It is indeed a pleasure and a privilege to be asked
to give this lecture in memory of a fine medical
scientist, whose career was cut so sadly short by
violence. In looking at the program today I cannot
help but think of another scientist, to whom this
field owes so much, whose life was also cut short
unexpectedly. Alick Isaacs, the discoverer of
interferon, was a brilliant medical scientist and it is
a matter of regret to us all that he did not live to
see the discovery which he had made, spread so
pervasively through the modern medical sciences. I
was fortunate enough to work with Alick Isaacs for
five years at the National Institute for Medical
Research and I was working with him when
interferon was discovered. At that time, I was
working on the nucleic acids of influenza virus, for
it was not known whether they contained RNA,
DNA or both; indeed it was still the days of 'steam
age' virology. Towards the end of this piece of
work Alick and I were discussing what to do next
when he suggested that I might work with him on
something interesting that he was doing on
interference. This was March 1957, shortly after the
discovery of interferon, and before any of the
published work had appeared. Little did I know
that a casual conversation would affect my career
in the way it has. Those were heady days for a
young scientist; for nearly every experiment that we
did was publishable. The early characterization was
relatively straightforward - pH 2 sensitivity,
degradation by the enzymes pepsin and trypsin,
ammonium sulphate precipitation, etc. It only got
much harder when I started to try and purify
interferon, a project which took many years of
work by a number of scientists to complete.
However, it is Alick himself who I remember so
vividly from that period. We assayed interferon by
using a haemaglutinin assay and pieces of a chick
chorio-allantoic membrane. Alick and I spent hours
sitting at the bench making the necessary two-fold
dilutions before adding the chick red cells. During
this period he gave me an education in virology.
Still a relatively new science, virology had grown
out of medical microbiology and indeed at that
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time only scientists with medical degrees could
become members of the Division of Virology at
Mill Hill.
For this reason I could not be a member of the
division and technically worked in chemistry,
hanging my coat there in the morning and
retrieving it as I left the building at night, but
spending all my day on the second floor in the
virus lab! It was great fun, learning virology in this
way, and when we got tired of talking about
science, Alick would sing snatches of opera which
other people in the lab had to identify and then
take their turn to reciprocate. However, what I
remember most of all was his quickness of mind;
after all, the basic phenomena which Alick had
observed and which led to the discovery of
interferon, had been seen by a number of other
investigators who had failed to see the significance
of the data - dismissing it as some spurious effect.
As I said, we titrated interferon using influenza
virus as a challenge and a haemaglutination assay
to measure the virus yield. The red cells took about
half an hour to settle - so that there was a period
of waiting after the titration had been finished
before we knew the results of the experiment. Alick
always carried a little hand lens in his lab coat
pocket and would use this to look at the perspex
plate in order to be able to tell as soon as possible
where the titration end point was going to be. Long
before the cells had settled fully he had interpreted
the experiment and planned two or three more. Just
occasionally his lens led him astray and after the
cells had settled he realised the answer was
different, but he would rise to this task very
quickly, always producing a stream of new ideas. I
found this extremely stimulating, for I had trained
in organic chemistry, then a more precise and
logical science but with less scope for the
imagination, and the way in which biology was
then yielding to a molecular approach has, of
course, fascinated my generation for the rest of our
lives. Alick thought broadly, suggesting ideas which
were sometimes wild but always testable. His vision
of interferon was broad; for example, when he
suggested that it could be regarded as a response to
foreign nucleic acids, stimulated by the ideas of
foreigness, which Burnet was talking about in
immunology at that time. He also tried to relate the
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action of interferon to an effect on oxidative
phosphorylation, later, however, shown to be an
artifact, and in the area that I went to talk about
today he did the seminal experiments and produced
ideas that even 25 years later are still provocative
and relevant.
All interferon work in the late 50s and early 60s
was carried out in the chick embryo system, either
using whole eggs or pieces of the chorioallantoic
membrane which lies underneath the shell. It was
not a very precise system and not suitable for the
biochemical investigations which came later in the
60s, but it was well understood biologically and lent
itself to a number of approaches. Isaacs and Baron
in 1960 were investigating the antiviral effect of
interferon in cells from fertile eggs of different ages
asking a question about Alick's oxidative
phosphorylation mechanism which is now
irrelevant. They fouind that 'there were striking
differences in the sensitivity to interferon from
embryos of different ages'. For example, they found
that although cells from 10 day old and 15 day old
embryos were almost equally sensitive to interferon,
cells from 8 day old embryos were about four-fold
less sensitive and cells from 6 day old embryos at
least sixteen-fold less sensitive. However, the
challenge virus grew equally well in all the cells.
Similar results were reported for 7 and 18 day old
mouse embryos although no details were given.
They also investigated production of interferon by
cells from chick embryos of different ages, and
found that the cells from 11 day old embryos
produced about 10 times as much interferon as
those from 6 day old embryos - when certain
corrections had been made for the number of cells
present in such membranes. They concluded that
'very young embryos, therefore, differ from older
embryos in being much less sensitive to the antiviral
action of interferon and in producing less interferon
after stimulation with ultra violet irradiated
influenza virus'. A similar study published the next
year (Baron & Isaacs, 1961) showed that this
change in the interferon system was also correlated
with changes in the susceptibility of chick embryos
to a variety of viruses (see also Morahan &
Grossberg, 1970a,b). Kari Cantell, in one of his
early papers (Cantell et al., 1965), also found that
about 8 times more chicken interferon was needed
to protect cultures made from 8 day old embryos
than to protect those from 15 day old embryos and
similar results were found by Grossberg &
Morahan (1971) using cultures from 6 day old and
13 day old embryos. They also found that more
interferon was needed to protect the younger cells.
At this point the study stopped. Isaacs interpreted
the results in an interesting and stimulating way to
which I will return later in the lecture, but people
had run out of ideas as to how to use the
experimental system and no other systems were
available for experimental study of the events
during early embryonic differentiation.
In 1976 I was on sabbatical leave in the
Department of Molecular, Cellular and Develop-
ment Biology at Boulder, Colorado, working
with Dr David Prescott on cell enucleation when
we had a visit from Dr John Lehman, who was
working in nearby Denver. He talked about his
work with embryonal carcinoma cells and it
occurred to us in conversation, that here was a
system at which we might look from the point of
interferon production and action. Embryonal
carcinoma cells are transformed stem cells, obtained
initially from the tumours arising in the gonads of
mice or following transplantation of early embryos
to ectopic sites. They resemble the cells of the inner
cell mass of developing embryos, most are
pluripotent and can differentiate both in vitro and
also in vivo to produce tumours containing a
variety of cell types in a disorganised fashion.
However, selection and adaptation of these cells for
tissue culture has resulted in the isolation of several
cell lines with more limited differentiation potential
and which may require treatment with chemicals to
initiate the differentiation process. Some are still
pluripotent and will differentiate spontaneously to
give a variety of cell types. Others differentiate
when treated with retinoic acid to give cells which
are typical of extra-embryonic parietal endoderm.
This differentiation in vitro can readily be
followed by the changes in shape and refractility of
the cells and also by changes in the cell antigens
which are exposed on the cell surface. They also
differ in their response to viruses (for a recent
summary see Sleigh, 1985). Viruses which multiply
exclusively in the cytoplasm will grow just as well
in undifferentiated cells as in their differentiated
progeny, but in particular, the RNA and DNA
tumour viruses do not multiply or express any viral
antigens in the undifferentiated cells although they
will do so in differentiated cells.
Here then was a biological system where massive
changes in the levels of gene transcription were
occurring and which could be manipulated in vitro,
and we decided to do a very simple experiment to
see whether the undifferentiated cells would make
or respond to interferon, both events which were
known to require the involvement of cellular genes.
The answers were satisfyingly clear cut.
Undifferentiated cells could neither respond to
interferon nor make it; differentiated cells did both,
and in an early attempt to study the changes that
occurred during differentiation, John Lehman and I
obtained some results suggesting that as
differentiation proceeded the interferon response
gradually was switched on. However, my sabbatical
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after returning to Britain, to be able to work with
Chris Graham in Oxford. I remember sitting on
Paddington Station together after an MRC
committee meeting planning the way we might do
the experiments. He had systems in which
differentiation could be initiated by treatment by
retinoic acid and in which over a period of several
days the cells changed morphology and the state of
differentiation without any change in cell number.
Over this period there was a similar change in
interferon production and also in interferon
sensitivity (Burke, et al., 1978). There was no doubt
that this change in the interferon system, governed
by genes on two different chromosomes,
accompanied cell differentiation.
To try and understand the mechanism of this
effect it is necessary to go back and look at some
of the work with the RNA and DNA tumour
viruses. Initially it was thought that the reason that
the undifferentiated cells failed to support
replication of these viruses was that viral transcripts
could not be processed correctly in undifferentiated
cells (Sehgal et al., 1979). This suggested an
interesting hypothesis that differentiation was
controlled at the level of RNA processing, but
further work has not supported this interpretation.
Work with polyoma virus showed that the virus
multiplication process was blocked at the point of
early transcription in embryonal carcinoma cells;
not much mature early region messenger RNA was
produced and there was no apparent accumulation
of unprocessed transcripts in the nucleus. Mutants
of polyoma have been isolated which are able to
productively infect embryonal carcinoma cells and
all these mutants have been shown to have
alterations in DNA sequence, upstream from this
start site of early region transcription, in regions
identified as containing enhancer-like activity.
These sequences stimulate the level of transcription
in a way in which is not understood, and it appears
that the normal enhancer functions poorly in these
embryonal carcinoma stem cells, whereas in
differentiated cells the enhancer appears to increase
in its activity, presumably as a result of some
change in the cellular environment associated with
differentiation. The mutants which are able to grow
productively in stem cells either have an altered
enhancer region or have duplicated the normal
enhancer.
Similar results were obtained with SV40 virus
although other factors may also play a role. This is
also true of the RNA tumour viruses where the
long terminal repeat function found in the viral
genome functions poorly in embryonal carcinoma
stem cells compared with the differentiated cells.
Here again other factors, notably the level of
methylation, affect the level at which integrated
genomes are ultimately expressed. However, studies
with all three viruses are consistent with a role for
enhancer sequences in regulating viral gene
expression. When the stem cells differentiate, the
SV40 and polyoma virus antigens are first
expressed from integrated viral genomes at about
the same time as other markers of the new cell type
appear. Thus it is possible that the expression of
both viral and cellular genes is activated by the
same mechanism. What little is known about the
mechanism of the switch-on of the interferon
system is consistent with this interpretation. For
example, it is well known that the arrangement of
the chromosome is such that regions which contain
genes available for transcription are more sensitive
to the effect of deoxyribonuclease treatment of
isolated nuclei than regions that do not contain
genes available for transcription. When cells are
treated with an inducer of interferon synthesis such
a change in accessibility to the enzyme deoxy-
ribonuclease is seen, suggesting that before the
interferon gene is transcribed the chromosomal
geometry has to change.
Studies with differentiating embryonal carcinoma
cells show that such changes occur when
differentiated embryonal carcinoma cells are treated
with an interferon inducer but not when
undifferentiated cells are so treated (Coveney et al.,
1984). Thus some very early step which leads to a
change in the geometry of the chromosome,
essential for the transcription of, in this case, the
interferon gene, cannot take place in stem cells, but
the nature ofthis control process is not understood.
Embryonal carcinoma cells have been widely
studied because the cells resemble the pluripotent
undifferentiated cells of the inner cell mass, and
because the processes occurring during
differentiation in vitro appear to mirror those
occurring in the early embryo. Therefore, it seemed
appropriate to ask whether the changes in the
interferon system seen in the tissue culture cells
were also seen in mouse embryos. In order to look
at this we needed a technique for looking at
interferon production in the very small numbers of
cells which could be obtained from the different
regions of the developing mouse embryo by micro-
dissection, and Denise Barlow, working with Dr
Graham and I, devised a rather simple method for
analysing the production of interferon by one or a
few mouse cells.
The cells to be tested are treated with a virus
inducer, then laid onto a layer of indicator cells
before covering the whole with agarose. Any
interferon which is formed diffuses out of the
treated mouse embryo cell and protects a number
of cells in the indicator layer. The agarose is then
removed, the indicator layer challenged with a
cytolytic virus and the cells then stained with a vital
stain. Any protection by interferon produced from304 D.C. BURKE
the mouse embryo cells will result in the formation
of small islands of protected cells in a sea of dead
cells.
The procedure, which is really a reverse infective
centre assay, is only qualitative, and can only
indicate whether such cells can produce interferon
at a detectable level or not. Micro-dissection of
mouse embryos of different ages clearly showed
that the inner cell mass could not produce
interferon, and that as the embryo differentiated the
series of membrane layers which are formed to
surround the inner cell mass are also capable of
interferon production (Barlow et al., 1984).
It is interesting that the change from interferon
negative to interferon positive occurred about 8
days after fertilization, that is about one third of
the way through pregnancy, a very similar time to
when the changes were observed to occur in Isaac's
early experiments using chick embryos. Thus the
changes taking place in tissue culture cells mirror
those occurring in the mouse embryos.
What is the significance of these findings?
Interpretation depends on whether interferon is
viewed solely as an anti-viral agent or as a
modulator of cell function. Isaacs originally
speculated that the lack of an interferon system in
the early embryo might explain why maternal
infection with rubella virus during the first three
months of pregnancy often leads to congenital
malformations while infection after the third month
rarely causes such malformations. As he said 'This
could be explained by assuming that ifthe embryo is
infected during the first third of the embryonic life.
it produces very little interferon and is very
insensitive to the anti-viral action of interferon, just
as occurs in the chick embryo. At later stages of
embryonic development it is assumed that the
interferon mechanism comes into play and limits
more effectively the viral infection.' (Isaacs &
Baron, 1969). This may be so but it does not deal
with what is perhaps the central question and that
is why should interferon not be made in the first
third of embryonic life if indeed it makes the
embryo more susceptible to the effects of virus
infection of the mother? Surely if the effect of
interferon is only that of protecting a cell against
virus infection, then it would be advantageous for
the organism always to have the interferon
mechanism available? After all the interferon
system is inducible and I find it difficult to see a
reason why such a useful inducible system should
not be available early in embryonic life if its only
function is to protect from viruses.
However, the whole theme of today's symposium
is to consider interferon as more than an anti-viral
agent. It is clear that interferon can affect cells in a
variety of ways, many of which involve the
regulation of transcription of cellular genes. Thus
genes involved in the anti-viral effect of interferon
are transcribed at much higher rates after interferon
treatment of cells. This is also true of some of the
genes controlling expression of surface antigens,
whole other genes can be down-regulated. Since
many of these genes do not have any obvious
relevance to virus multiplication we must try to
reinterpret the data in terms of interferons' wider
potential. Indeed, the effects that interferon has on
a number of differentiating cell systems have been
studied and the results recently reviewed by Rossi
(1985). Looking at the different systems, it is
probably useful to draw a distinction between three
different types. First, the system typified by the
embryonal carcinoma cell, that is cells undergoing
the initial stages of differentiation from a
pluripotent stem cell. I have described the evidence
showing that stem cells are not susceptible to the
effects of interferon. This is not because they lack
interferon receptors, indeed, such receptors have
been found and some of the enzymes involved in
interferon's anti-viral mechanism can be stimulated
by treatment with interferon. (Wood &
Hovanessian, 1979; Aguet et al., 1981; Silverman et
al., 1983; Krause et al., 1985). However, interferon
has no effect as an anti-viral agent, does not inhibit
the growth of the cells nor inhibit the process of
differentiation. Second, there is the effect of
interferon on the terminal differentiation of cells
induced by the addition of growth factors or other
agents. In general, interferon inhibits such
processes. Thus it inhibits the ability of rat cells to
produce tyrosine amino transferase in response to
dexamethasone and the induction by hydro-
cortisone of glutamine synthetase in chick
embryonic neural retina. It inhibits haemaglobin
synthesis in Friend leukaemia cells which have
been treated with DMSO, it inhibits the stimulation
of L-ornithine decarboxylase produced by serum in
quiesent cultures of Swiss 3T3 cells, and so on
(reviewed by Rossi, 1985). I do not know of any
case where the mechanism of such an effect has
been elucidated.
Finally, interferon can stimulate the activities of
genes in a number of cells which do not depend
upon such external agents. The affects on the
immune system are widely known. These have been
analysed at the cellular level and also at the
molecular level, showing, for example, that the rate
of transcription of the major histocompatibility
complex genes is enhanced at the transcriptional
level (reviewed by Rossi, 1985). It is now clear that
there are at least 25 genes in susceptible cells whose
rate of transcription is increased by exposure of the
cells to interferon.
Over the last few years it has become clear that
cells can be induced to undergo profound changes
by addition of the so-called growth factors, and weINTERFERON AND CELL DIFFERENTIATION 305
are accustomed to the wide ranging affects of this
group of hormone type molecules. Should
interferon be added to this list? And if so where
does the interferon come from? Not from virus
infection, since that would imply an obligatory role
of virus infection in triggering such changes.
However, it is known that a number of non-viral
substances can induce interferon and there are
persistent and increasingly convincing reports of the
presence of small amounts of endogenous interferon
in whole animals (Bocci, 1985). There are also
reports of the spontaneous production of interferon
by differentiating systems and a recent report shows
that if such interferon is neutralised by the addition
of the appropriate antibody, the differentiation
process does not go to completion (Yorden et al.,
1984). It is, therefore, tempting to speculate that
interferon may be one of a group of substances
which determine the later stages of differentiation.
Its inhibitory effect on those systems which are
triggered by other growth factors could be seen as a
reflection of counteracting systems, and its affect on
terminal differentiation as a type of autocatalysis.
That is, interferon produced by cells which have
travelled through the early stages of cell
differentiation are exposed to inducers from an as
yet unidentified source, and this interferon is
essential for the later stages. Certainly the
differentiation of NK cells as a response to
interferon treatment has been interpreted in this
way. It is clear that such later stages would not be
stimulated until the cells themselves become
competent to respond to interferon, and this
process appears to occur about one third of the
way through embryonic development. It is still not
clear why the stages of early differentiation
including the critically important stages of
determination should not be affected by interferon.
But it is clear that the genome of such early
differentiating systems is controlled in such a way
as to neither make nor respond to interferon.
Thus, we can take Alick Isaac's story a little
further. His early observations have held up and
have been explored in a much more sophisticated
system, but still leave many questions to be
resolved. However, the evidence accumulating
over the last few years has strengthened the view
that interferon may indeed play a role in the later
stages of differentiation of a wide variety of cells. It
is, of course, not alone in doing this and it looks as
if through our investigation of the interferon
system, we have stumbled into an area which will
provide many more years of fascinating work. This
has been perhaps one of the most enduring qualities
of the interferon system; no longer is it, as it was in
the early 60s, an obsession of a few scientists
absorbed with what many saw to be a peripheral
and rather trivial research area. The importance of
the interferon system does not rest on solely
whether it turns out to be a clinically useful agent
against viruses or cancer; in my view its importance
will remain as a lever to understand a little more of
that vast network of regulated gene expression that
lies behind both the formation and the activity of
differentiated cells.
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